Clinical Development

weight loss drugs obesity

Biotech

Wave, Structure stocks double on obesity data readouts

Wave issued phase 1 results on its siRNA candidate, while Structure plans to advance its oral GLP-1 receptor agonist into late-stage testing.

Fraiser Kansteiner Dec 8, 2025 10:50am

follow the leader arrow growth crowd

CatalYm C-suite shake-up sees 4 new faces, 3 departures

Sep 15, 2025 10:53am

candle candles

Biopsies illuminate potential of Candel's prostate cancer drug

May 22, 2025 6:57pm

White arrow on a road pointing to the rising sun

Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

Apr 28, 2025 7:25am

Hiker having trouble climbing mountain

ALX Oncology doubles down as lead asset fails 2 phase 2 trials

Apr 25, 2025 2:25pm

Blood pressure monitor next to toy heart

Large trial reveals link between lowered BP and dementia risk

Apr 24, 2025 11:33am